We formed over 250 partnerships as part of our prior AIMS program with top universities and research institutes around the world, many generating joint IP in the resulting compounds. As part of the AIMS program, we addressed over 600 unique targets for collaboration that encompassed every major disease area.
Contact us to learn more about our academic partnering opportunities.
Contact Academic Partnering